Trump to Announce a Drug Pricing Deal With AstraZeneca

The move would follow a similar agreement with Pfizer. Other companies are engaged in talks with the White House that would help them avoid tariffs on their products overseas.

News
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat

The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.

News